SEC Tracker
Get the app

CRISPR Therapeutics CRSP

CRISPR Therapeutics reports stock option and RSU grant

Naimish Patel, insider filing for CRSP

Form
4
Filed
Importance
Routine
  1. Stock option for 24,000 shares granted on Oct 26, 2026
  2. Restricted stock units (shares paid out over time) for 12,000 shares granted on Oct 26, 2026
  3. Vesting for stock option over 48 months starting Nov 26, 2026

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when CRISPR Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025
  2. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  3. Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
  4. Merus MRUS
  5. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025